Hugging Face's logo

Datasets:
Treza12
/
newdatasetfourCIPA

Modalities:
Image
Text
Formats:
parquet
Size:
1K - 10K
Libraries:
Datasets
pandas
Dataset card Data Studio Files Community
1
Dataset Viewer
Auto-converted to Parquet
USUBJID
stringclasses
60 values
prompt
stringclasses
1 value
image
imagewidth (px)
1k
1k
report
stringclasses
7 values
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1001
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Ranolazine
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
1002
ECG effects of ranolazine, verapamil, lopinavir+ritonavir, chloroquine, dofetilide, diltiazem, and dofetilide+diltiazem in a small clinical study.
This is the ECG report with PARAM of HR COMPTYPE of Placebo group BASETYPE of Day 1 predose and TRTP of Lopinavir+Ritonavir
End of preview. Expand in Data Studio
README.md exists but content is empty.
Downloads last month
1
Size of downloaded dataset files:
14.9 MB
Size of the auto-converted Parquet files:
14.9 MB
Number of rows:
4,020